Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Biomarkers of Traumatic Brain Injury: Diagnostic, Prognostic, and Ph…

UChicago Medicine

R. Diaz-Arrastia

How Post-Viral Illness Causes Post-Exertional Malaise

The Institute for Neuro-Immune Medicine

H. Pomroy, L. Jason

Reducing the Burden of Traumatic Brain Injuries by Improving Recovery

BRAIN PONDERINGS podcast with Mark Mattson

D. Menon, M. Mattson

Penetrating TBI Algorithms

UChicago Medicine

A. Valadka

Cognitive Disorders

ZINCARE

M. Mataa

Approach to Cognitive Impairment in Adults

ZINCARE

M. Mataa

AAIC 2024 Insights: Effects of Gut Microbiota Dysbiosis on Cognitive…

AAIC 2024 Insights Hub

Y. (Laura) Zhang

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Updates in Dementia

2023 Conference Coverage

P. Tipton

New & Emerging Treatments in Alzheimer's Disease

University of Miami

E. Crocco

Alzheimer's: Clinical Pearls

Lawrence Robbins

Anatomical Neurological Complications in Long-COVID and ME/CFS

Bateman Horne Center

B. Yellman, T. Dowell

AAIC 2024 Insights: Developing an AI Algorithm to Detect Predictors …

AAIC 2024 Insights Hub

J. Butler

AAIC 2024 Insights: Potential of Targeting the Alpha-1 Adrenergic Re…

AAIC 2024 Insights Hub

S. G. Pattanashetty

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay

AAIC 2024 Insights: qEEG as Biomarker for Alzheimer's Disease - Inve…

AAIC 2024 Insights Hub

C. Simfukwe

A New Era for Brain Health in Primary Care: New Drugs and Diagnostics

University of Kansas Medical Center

J. M. Burns